Health-related Internet use and treatment adherence: A transdiagnostic comparison of outpatients with major depressive disorder and schizophrenia.
Adult
Age Factors
Depressive Disorder, Major
/ diagnosis
Female
Humans
Information Seeking Behavior
Internet Use
/ statistics & numerical data
Male
Middle Aged
Outpatients
/ statistics & numerical data
Psychotic Disorders
Schizophrenia
/ diagnosis
Sex Factors
Surveys and Questionnaires
Treatment Adherence and Compliance
Internet
major depressive disorder
schizophrenia
treatment adherence
Journal
PsyCh journal
ISSN: 2046-0260
Titre abrégé: Psych J
Pays: Australia
ID NLM: 101598595
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
02
09
2019
revised:
03
01
2020
accepted:
21
02
2020
pubmed:
20
3
2020
medline:
30
12
2020
entrez:
20
3
2020
Statut:
ppublish
Résumé
Treatment adherence is relevant for clinical and economic outcome in affective disorders as well as psychosis. Knowledge concerning the disease and its treatment might influence patients' willingness to follow the health-care providers' recommendations and mutual decision-making. In the current study, we investigated how Internet surfing for health-related issues and attitude toward the relevance of the online information impact treatment adherence in major depressive disorder (MDD) and schizophrenia (SZ). A total of 83 outpatients (59 MDD, 24 SZ) participated in a survey. A multiple linear regression model with "exposure," "attitude," "diagnosis," and their interaction as regressors was significant predictive of medication-adherence rating scores, R
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
174-184Subventions
Organisme : Behring-Roentgen-Foundation
ID : 64-0016
Organisme : Rhoen-Klinikum AG
ID : FI22/2015
Organisme : University Medical Center Giessen and Marburg
ID : UKGM, 27/2015 MR
Informations de copyright
© 2020 The Authors. PsyCh Journal published by Institute of Psychology, Chinese Academy of Sciences and John Wiley & Sons Australia, Ltd.
Références
Ascher-Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S., & Swanson, J. W. (2006). Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry, 67(3), 453-460. https://doi.org/10.4088/JCP.v67n0317
Bauer, M., Severus, E., Möller, H.-J., Young, A. H., & WFSBP Task Force on Unipolar Depressive Disorders (2017). Pharmacological treatment of unipolar depressive disorders: Summary of WFSBP guidelines. International Journal of Psychiatry in Clinical Practice, 21(3), 166-176. https://doi.org/10.1080/13651501.2017.1306082
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4(6), 561-571. https://doi.org/10.1001/archpsyc.1961.01710120031004
Carpenter, D. M., DeVellis, R. F., Fisher, E. B., DeVellis, B. M., Hogan, S. L., & Jordan, J. M. (2010). The effect of conflicting medication information and physician support on medication adherence for chronically ill patients. Patient Education and Counseling, 81(2), 169-176. https://doi.org/10.1016/j.pec.2009.11.006
Charlson, F. J., Ferrari, A. J., Santomauro, D. F., Diminic, S., Stockings, E., Scott, J. G., … Whiteford, H. A. (2018). Global epidemiology and burden of schizophrenia: Findings from the global burden of disease study 2016. Schizophrenia Bulletin, 44(6), 1195-1203. https://doi.org/10.1093/schbul/sby058
Chaudhari, B., Saldanha, D., Kadiani, A., & Shahani, R. (2017). Evaluation of treatment adherence in outpatients with schizophrenia. Industrial Psychiatry Journal, 26(2), 215-222. https://doi.org/10.4103/ipj.ipj_24_17
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., … Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7
Deary, I. J., Gale, C. R., Stewart, M. C. W., Fowkes, F. G. R., Murray, G. D., Batty, G. D., & Price, J. F. (2009). Intelligence and persisting with medication for two years: Analysis in a randomised controlled trial. Intelligence, 37(6), 607-612. https://doi.org/10.1016/j.intell.2009.01.001
Dilling, H., Mombour, W., Schmidt, M. H., Schulte-Markwort, E., & Remschmidt, H. (2015). Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F) klinisch-diagnostische Leitlinien (10. Auflage, unter Berücksichtigung der Änderungen entsprechend ICD-10-GM 2015.). Bern: Hogrefe Verlag.
El-Missiry, A., Elbatrawy, A., El Missiry, M., Moneim, D. A., Ali, R., & Essawy, H. (2015). Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia. Journal of Psychiatric Research, 70, 106-112. https://doi.org/10.1016/j.jpsychires.2015.09.006
Guy, W. (1976). Clinical Global Impression (CGI). In ECDEU Assessment Manual for Psychopharmacology (p. 603). Rockville, MD: U.S. Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration. National Institute of Mental Health (U.S.). Psychopharmacology Research Branch; Early Clinical Drug Evaluation Program.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-62. https://doi.org/10.1136/jnnp.23.1.56
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthøj, B., Gattaz, W. F., … WFSBP Task Force on Treatment Guidelines for Schizophrenia (2017). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - A short version for primary care. International Journal of Psychiatry in Clinical Practice, 21(2), 82-90. https://doi.org/10.1080/13651501.2017.1291839
Ho, S. C., Chong, H. Y., Chaiyakunapruk, N., Tangiisuran, B., & Jacob, S. A. (2016). Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review. Journal of Affective Disorders, 193, 1-10. https://doi.org/10.1016/j.jad.2015.12.029
Ho, S. C., Jacob, S. A., & Tangiisuran, B. (2017). Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study. PLoS One, 12(6), e0179290. https://doi.org/10.1371/journal.pone.0179290
Hong, J., Reed, C., Novick, D., Haro, J. M., & Aguado, J. (2011). Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: Results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Research, 190(1), 110-114. https://doi.org/10.1016/j.psychres.2011.04.016
Hung, C.-I. (2014). Factors predicting adherence to antidepressant treatment. Current Opinion in Psychiatry, 27(5), 344-349. https://doi.org/10.1097/YCO.0000000000000086
Hung, C. I., Wang, S. J., Liu, C. Y., Hsu, S. C., & Yang, C. H. (2011). Comorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorder. Comprehensive Psychiatry, 52(4), 370-377. https://doi.org/10.1016/j.comppsych.2010.08.005
Im, H., & Huh, J. (2017). Does health information in mass media help or hurt patients? Investigation of potential negative influence of mass media health information on patients' beliefs and medication regimen adherence. Journal of Health Communication, 22(3), 214-222. https://doi.org/10.1080/10810730.2016.1261970
Jones, S. H., Thornicroft, G., Coffey, M., & Dunn, G. (1995). A brief mental health outcome scale: Reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry, 166(5), 654-659. https://doi.org/10.1192/bjp.166.5.654
Jónsdóttir, H., Opjordsmoen, S., Birkenaes, A. B., Simonsen, C., Engh, J. A., Ringen, P. A., … Andreassen, O. A. (2012). Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatrica Scandinavica, 127(1), 23-33. https://doi.org/10.1111/j.1600-0447.2012.01911.x
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261-276. https://doi.org/10.1093/schbul/13.2.261
Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996). Compliance therapy in psychotic patients: Randomised controlled trial. BMJ, 312(7027), 345-349. https://doi.org/10.1136/bmj.312.7027.345
Kishimoto, T., Agarwal, V., Kishi, T., Leucht, S., Kane, J. M., & Correll, C. U. (2013). Relapse prevention in schizophrenia: A systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Molecular Psychiatry, 18(1), 53-66. https://doi.org/10.1038/mp.2011.143
Krivoy, A., Balicer, R. D., Feldman, B., Hoshen, M., Zalsman, G., Weizman, A., & Shoval, G. (2015). The impact of age and gender on adherence to antidepressants: A 4-year population-based cohort study. Psychopharmacology, 232(18), 3385-3390. https://doi.org/10.1007/s00213-015-3988-9
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry, 63(10), 892-909. https://doi.org/10.4088/JCP.v63n1007
Lehrl, S., Triebig, G., & Fischer, B. (1995). Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurologica Scandinavica, 91, 335-345. https://doi.org/10.1111/j.1600-0404.1995.tb07018.x
Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., … Davis, J. M. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors. American Journal of Psychiatry, 174(10), 927-942. https://doi.org/10.1176/appi.ajp.2017.16121358
Lingam, R., & Scott, J. (2002). Treatment non-adherence in affective disorders. Acta Psychiatrica Scandinavica, 105(3), 164-172. https://doi.org/10.1034/j.1600-0447.2002.1r084.x
Linn, A. J., van Weert, J. C. M., Gebeyehu, B. G., Sanders, R., Diviani, N., Smit, E. G., & van Dijk, L. (2018). Patients' online information-seeking behavior throughout treatment: The impact on medication beliefs and medication adherence. Health Communication, 34, 1461-1468. https://doi.org/10.1080/10410236.2018.1500430
Manteuffel, M., Williams, S., Chen, W., Verbrugge, R. R., Pittman, D. G., & Steinkellner, A. (2014). Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. Journal of Women's Health, 23(2), 112-119. https://doi.org/10.1089/jwh.2012.3972
Murray, R. M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., … Taylor, D. (2016). Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics? The British Journal of Psychiatry, 209(5), 361-365. https://doi.org/10.1192/bjp.bp.116.182683
Novick, D., Haro, J. M., Suarez, D., Perez, V., Dittmann, R. W., & Haddad, P. M. (2010). Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research, 176, 109-113. https://doi.org/10.1016/j.psychres.2009.05.004
Rolnick, S. J., Pawloski, P. A., Hedblom, B. D., Asche, S. E., & Bruzek, R. J. (2013). Patient characteristics associated with medication adherence. Clinical Medicine and Research, 11(2), 54-65. https://doi.org/10.3121/cmr.2013.1113
Sajatovic, M., Valenstein, M., Blow, F. C., Ganoczy, D., & Ignacio, R. V. (2006). Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders, 8(3), 232-241. https://doi.org/10.1111/j.1399-5618.2006.00314.x
Sawada, N., Uchida, H., Suzuki, T., Watanabe, K., Kikuchi, T., Handa, T., & Kashima, H. (2009). Persistence and compliance to antidepressant treatment in patients with depression: A chart review. BMC Psychiatry, 9, 38. https://doi.org/10.1186/1471-244X-9-38
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2015). Prevention of relapse and recurrence in adults with major depressive disorder: Systematic review and meta-analyses of controlled trials. The International Journal of Neuropsychopharmacology, 19(2), pyv076. https://doi.org/10.1093/ijnp/pyv076
Stentzel, U., van den Berg, N., Schulze, L. N., Schwaneberg, T., Radicke, F., Langosch, J. M., … Grabe, H.-J. (2018). Predictors of medication adherence among patients with severe psychiatric disorders: Findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry, 18(1), 155. https://doi.org/10.1186/s12888-018-1737-4
Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247. https://doi.org/10.1016/S0920-9964(99)00130-9
Valenstein, M., Ganoczy, D., McCarthy, J. F., Myra Kim, H., Lee, T. A., & Blow, F. C. (2006). Antipsychotic adherence over time among patients receiving treatment for schizophrenia: A retrospective review. The Journal of Clinical Psychiatry, 67(10), 1542-1550. https://doi.org/10.4088/jcp.v67n1008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17107245
Velligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & Docherty, J. P. (2017). Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Preference and Adherence, 11, 449-468. https://doi.org/10.2147/PPA.S124658
Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004). Partial compliance and risk of rehospitalization among California medicaid patients with schizophrenia. Psychiatric Services, 55, 886-891. https://doi.org/10.1176/appi.ps.55.8.886
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., … Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet, 382(9904), 1575-1586. https://doi.org/10.1016/S0140-6736(13)61611-6
World Health Organization. (2003). Adherence to long-term medications: Evidence for action. Retrieved from http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf